Many staff were left bemused last week after being told Preston and Porter had been put on ‘special leave’.
But the agency’s UK head of healthcare Claire Martin insisted that the senior management losses had ‘had no impact in terms of healthcare’.
Instead, she highlighted two new recruits. Katy Compton-Bishop, who recently quit her post as PR director at Euro RSCG Life UK, will join Ruder Finn as associate director in a few weeks’ time. She replaces Paul Gittins, who quit to set up Red Health with Ruder Finn’s European innovation director Pat Pearson (PRWeek, 6 June).
Compton-Bishop will lead across the agency’s work on Novartis’ oncology portfolio, which houses brands such as breast cancer drug Femara.
Meanwhile, Caroline Tatum joined as an account director last week. She was previously in the same role at Red Door Communications, where she spent five years.
Tatum will work on the Novartis business as well as public health accounts; these include the GAVI Alliance, which works on improving children’s access to vaccines in poor countries.
The new hires bring the headcount in Ruder Finn’s London healthcare practice to 30.